Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- 最新申報
- 2026/8/14
2025 年第 3 季持倉
持倉截至 2025/9/30，2025/11/14 申報。只含多頭部位，變化是跟 2025 年第 2 季比股數。
- 持股檔數
- 101
- 較 2025 年第 2 季 0
- 總值
- $4.22 億
- 較 2025 年第 2 季 +$3,911 萬 (+10.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,507,025 | $3,044 萬 | 7.2% | −113,965−7.0% | 減碼 | 歷史 |
| NICENICE Ltd. | SPONSORED ADR | 157,400 | $2,279 萬 | 5.4% | +157,400 | 新進 | 歷史 |
| TSEMTower Semiconductor Ltd | SHS NEW | 311,802 | $2,254 萬 | 5.3% | +47,080+17.8% | 加碼 | 歷史 |
| NVMINova Ltd. | COM | 43,896 | $1,403 萬 | 3.3% | −31,940−42.1% | 減碼 | 歷史 |
| Invesco QQQ Trust Series I46090E103 | ETF | 22,960 | $1,378 萬 | 3.3% | +22,960 | 新進 | – |
| BIIBBiogen Inc. | COM | 82,738 | $1,159 萬 | 2.7% | 00.0% | 不變 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 352,558 | $1,060 萬 | 2.5% | +252,473+252.3% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 135,060 | $1,036 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| SNYSanofi | SPONSORED ADR | 219,515 | $1,036 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 161,517 | $887.7 萬 | 2.1% | −165,201−50.6% | 減碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 219,910 | $833.9 萬 | 2.0% | −261,064−54.3% | 減碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 991,142 | $781.0 萬 | 1.9% | +4240.0% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 10,040 | $766.1 萬 | 1.8% | −1,500−13.0% | 減碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 40,831 | $757.1 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM NEW | 75,743 | $725.3 萬 | 1.7% | −62,258−45.1% | 減碼 | 歷史 |
| FBRXForte Biosciences, Inc. | COM NEW | 474,309 | $711.5 萬 | 1.7% | −20,800−4.2% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 387,716 | $596.5 萬 | 1.4% | −1,183,848−75.3% | 減碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 643,957 | $589.2 萬 | 1.4% | −156,000−19.5% | 減碼 | 歷史 |
| NVONovo Nordisk A S | ADR | 105,677 | $586.4 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| ABBVAbbVie Inc. | Stock | 25,256 | $584.8 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| CLBTCellebrite DI Ltd. | ORDINARY SHARES | 298,948 | $554.0 萬 | 1.3% | +298,948 | 新進 | 歷史 |
| ANNXAnnexon, Inc. | COM | 1,794,387 | $547.3 萬 | 1.3% | +30,000+1.7% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 426,518 | $539.5 萬 | 1.3% | +205,102+92.6% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 207,764 | $537.5 萬 | 1.3% | −211,776−50.5% | 減碼 | 歷史 |
| Solaredge Technologies, Inc.83417MAE4 | NOTE 2.250% 7/0 | 4,000,000 | $533.3 萬 | 1.3% | +4,000,000 | 新進 | – |
| GSKGSK plc | ADR | 122,000 | $526.6 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| SEDGSolaredge Technologies, Inc. | COM | 140,966 | $521.6 萬 | 1.2% | +13,000+10.2% | 加碼 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 431,693 | $518.0 萬 | 1.2% | +37,000+9.4% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 583,105 | $496.8 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 173,931 | $487.0 萬 | 1.2% | +78,000+81.3% | 加碼 | 歷史 |
| SVRASavara Inc | COM | 1,350,333 | $482.1 萬 | 1.1% | +40,100+3.1% | 加碼 | 歷史 |
| NVSNovartis AG | ADR | 37,000 | $474.5 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| RAPPRapport Therapeutics, Inc. | COM | 157,533 | $467.9 萬 | 1.1% | +157,533 | 新進 | 歷史 |
| VRNSVaronis Systems Inc | COM | 73,900 | $424.7 萬 | 1.0% | +73,900 | 新進 | 歷史 |
| IMVTImmunovant, Inc. | COM | 256,743 | $413.9 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| MRKMerck & Co., Inc. | Stock | 48,600 | $407.9 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 154,343 | $400.2 萬 | 0.9% | −202,110−56.7% | 減碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 504,409 | $344.5 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ESLTElbit Systems Ltd | Stock | 6,740 | $343.6 萬 | 0.8% | +740+12.3% | 加碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 363,947 | $342.1 萬 | 0.8% | −387,500−51.6% | 減碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 166,765 | $341.4 萬 | 0.8% | +38,250+29.8% | 加碼 | 歷史 |
| MDWDMediWound Ltd. | SHS NEW | 185,270 | $333.9 萬 | 0.8% | +185,270 | 新進 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,280,233 | $331.6 萬 | 0.8% | −679,377−34.7% | 減碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 148,900 | $317.8 萬 | 0.8% | −26,000−14.9% | 減碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 57,901 | $306.9 萬 | 0.7% | −51,856−47.2% | 減碼 | 歷史 |
| CAMTCamtek Ltd | ORD | 29,048 | $305.1 萬 | 0.7% | −2,928−9.2% | 減碼 | 歷史 |
| AMZNAmazon Com Inc | Stock | 13,760 | $302.1 萬 | 0.7% | −18,681−57.6% | 減碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 407,709 | $300.5 萬 | 0.7% | +224,615+122.7% | 加碼 | 歷史 |
| PHVSPharvaris N.V. | COM | 119,406 | $297.9 萬 | 0.7% | −190,525−61.5% | 減碼 | 歷史 |
| METAMeta Platforms, Inc. | Stock | 3,924 | $288.2 萬 | 0.7% | −4,602−54.0% | 減碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 41,606 | $281.3 萬 | 0.7% | +41,606 | 新進 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 60,000 | $280.2 萬 | 0.7% | +60,000 | 新進 | 歷史 |
| ORAOrmat Technologies, Inc. | COM | 29,000 | $279.1 萬 | 0.7% | −49,000−62.8% | 減碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 100,000 | $272.1 萬 | 0.6% | +100,000 | 新進 | 歷史 |
| AMGNAmgen Inc | Stock | 9,500 | $268.1 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| AMDAdvanced Micro Devices Inc | Stock | 15,470 | $250.3 萬 | 0.6% | +7,220+87.5% | 加碼 | 歷史 |
| ACOGAlpha Cognition Inc. | COM NEW | 338,752 | $220.5 萬 | 0.5% | −37,897−10.1% | 減碼 | 歷史 |
| PFEPfizer Inc | Stock | 86,000 | $219.1 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| HELPHelus Pharma Inc. | COM NEW | 370,376 | $218.2 萬 | 0.5% | −27,933−7.0% | 減碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 245,522 | $217.3 萬 | 0.5% | +10,000+4.2% | 加碼 | 歷史 |
| AVGOBroadcom Inc. | Stock | 6,555 | $216.3 萬 | 0.5% | +6,555 | 新進 | 歷史 |
| CEVACeva Inc | COM | 81,085 | $214.1 萬 | 0.5% | +32,165+65.8% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 40,746 | $211.6 萬 | 0.5% | −46,362−53.2% | 減碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 85,840 | $209.8 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| SKYESkye Bioscience, Inc. | COM NEW | 478,928 | $188.2 萬 | 0.4% | −59,506−11.1% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 251,225 | $182.9 萬 | 0.4% | −6,177−2.4% | 減碼 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 115,908 | $181.9 萬 | 0.4% | +115,908 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 50,000 | $180.1 萬 | 0.4% | +50,000 | 新進 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 510,343 | $175.0 萬 | 0.4% | +200,000+64.4% | 加碼 | 歷史 |
| IMNMImmunome Inc. | COM | 147,200 | $172.4 萬 | 0.4% | +147,200 | 新進 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 820,000 | $164.0 萬 | 0.4% | +820,000 | 新進 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM NEW | 629,470 | $149.8 萬 | 0.4% | +614,799+4,190.6% | 加碼 | 歷史 |
| QUREuniQure N.V. | SHS | 24,900 | $145.3 萬 | 0.3% | +24,900 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 63,660 | $144.1 萬 | 0.3% | −50,686−44.3% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 98,526 | $141.5 萬 | 0.3% | −45,167−31.4% | 減碼 | 歷史 |
| IBITiShares Bitcoin Trust ETF | ETF | 21,455 | $139.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 440,114 | $136.9 萬 | 0.3% | −115,700−20.8% | 減碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 91,155 | $136.8 萬 | 0.3% | −54,217−37.3% | 減碼 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 85,747 | $135.4 萬 | 0.3% | +20,068+30.6% | 加碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 408,146 | $133.5 萬 | 0.3% | −11,854−2.8% | 減碼 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 175,371 | $123.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $123.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SABSSAB Biotherapeutics, Inc. | COM NEW | 566,395 | $113.8 萬 | 0.3% | +566,395 | 新進 | 歷史 |
| ENPHEnphase Energy, Inc. | Stock | 26,700 | $94.5 萬 | 0.2% | +26,700 | 新進 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 199,761 | $93.3 萬 | 0.2% | +199,761 | 新進 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 434,837 | $87.4 萬 | 0.2% | +225,000+107.2% | 加碼 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 260,385 | $84.1 萬 | 0.2% | +63,750+32.4% | 加碼 | 歷史 |
| PEPGPepGen Inc. | COM | 171,467 | $79.2 萬 | 0.2% | +15,000+9.6% | 加碼 | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 17,500 | $78.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 78,307 | $69.1 萬 | 0.2% | −85,000−52.0% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 42,571 | $64.4 萬 | 0.2% | +42,571 | 新進 | 歷史 |
| ETNB89bio, Inc. | COM | 39,675 | $58.3 萬 | 0.1% | −166,000−80.7% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 71,010 | $50.9 萬 | 0.1% | +71,010 | 新進 | 歷史 |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 179,425 | $47.2 萬 | 0.1% | −5,087−2.8% | 減碼依 1 比 4 拆股換算 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 12,496 | $43.1 萬 | 0.1% | −190,500−93.8% | 減碼 | 歷史 |
| APREAprea Therapeutics, Inc. | COM NEW | 270,000 | $39.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 50,000 | $36.6 萬 | 0.1% | +50,000 | 新進 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 60,454 | $16.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 21,918 | $16.5 萬 | <0.1% | +21,918 | 新進 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM | 295,187 | $12.5 萬 | <0.1% | −1,604,110−84.5% | 減碼 | 歷史 |
選擇權（13 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| MRUSMerus N.V. | COM | – | $1,412 萬 |
| CDTXCidara Therapeutics, Inc. | COM NEW | – | $957.6 萬 |
| BBIOBridgeBio Pharma, Inc. | COM | – | $675.2 萬 |
| QUREuniQure N.V. | SHS | $437.8 萬 | – |
| iShares Tr464287432 | 20 YR TR BD ETF | – | $420.0 萬 |
| SRPTSarepta Therapeutics, Inc. | COM | – | $289.1 萬 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | – | $265.0 萬 |
| TVTXTravere Therapeutics, Inc. | COM | – | $243.3 萬 |
| ROIVRoivant Sciences Ltd. | SHS | – | $229.4 萬 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | – | $140.0 萬 |
| TRVITrevi Therapeutics, Inc. | COM | – | $118.2 萬 |
| ELDNEledon Pharmaceuticals, Inc. | COM | $51.8 萬 | – |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | – | $7.17 萬 |
2025 年第 2 季之後清倉（23 檔）
2025 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 2 季股數 | 2025 年第 2 季市值 | 2025 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| NVDANVIDIA Corp | Stock | 54,515 | $861.3 萬 | 2.3% | 歷史 |
| MSFTMicrosoft Corp | Stock | 11,792 | $586.5 萬 | 1.5% | 歷史 |
| Ormat Technologies, Inc.686688AC6 | DEBT 2.500% 7/1 | 5,037,000 | $561.0 萬 | 1.5% | – |
| TVTXTravere Therapeutics, Inc. | COM | 335,333 | $496.3 萬 | 1.3% | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 126,000 | $357.8 萬 | 0.9% | – |
| AMATApplied Materials Inc | Stock | 18,000 | $329.5 萬 | 0.9% | 歷史 |
| UBERUber Technologies, Inc | Stock | 30,000 | $279.9 萬 | 0.7% | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 159,323 | $272.4 萬 | 0.7% | 歷史 |
| PANWPalo Alto Networks Inc | Stock | 13,114 | $268.4 萬 | 0.7% | 歷史 |
| WIXWix.com Ltd. | SHS | 16,931 | $268.3 萬 | 0.7% | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 57,497 | $203.7 萬 | 0.5% | 歷史 |
| CRMSalesforce, Inc. | Stock | 6,800 | $185.4 萬 | 0.5% | 歷史 |
| Cyberark Software LtdM2682V108 | SHS | 4,000 | $162.8 萬 | 0.4% | – |
| MRVLMarvell Technology, Inc. | COM | 18,730 | $145.0 萬 | 0.4% | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 128,780 | $120.8 萬 | 0.3% | 歷史 |
| NNDMNano Dimension Ltd. | SPONSORD ADS NEW | 717,518 | $116.2 萬 | 0.3% | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 7,335 | $100.8 萬 | 0.3% | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM | 447,939 | $89.6 萬 | 0.2% | 歷史 |
| SSentinelOne, Inc. | CL A | 27,000 | $49.4 萬 | 0.1% | 歷史 |
| CGNTCognyte Software Ltd. | ORD SHS | 45,181 | $41.7 萬 | 0.1% | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 58,539 | $26.8 萬 | 0.1% | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 50,190 | $24.4 萬 | 0.1% | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 328,562 | $12.1 萬 | <0.1% | 歷史 |